Status:

ACTIVE_NOT_RECRUITING

A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy

Lead Sponsor:

AbbVie

Conditions:

Acute Myeloid Leukemia

Eligibility:

All Genders

18+ years

Brief Summary

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow and is the most common acute leukemia in adults. This study will evaluate how well venetoclax in combination with azacitidine work...

Eligibility Criteria

Inclusion

  • Confirmed diagnosis of primary or secondary acute myeloid leukemia (AML), deemed ineligible for intensive induction chemotherapy because of age, performance status, comorbidities or any other clinical reason as defined by the treating physician.
  • Investigator decision on patient treatment with venetoclax + azacitidine must have been reached prior to and independently of recruitment in the study.
  • Treatment prescribed in accordance with the applicable approved label and local regulatory and reimbursement policies.

Exclusion

  • Participants affected by Acute Promyelocytic Leukemia.
  • Prior treatment for AML, excluding hydroxyurea.
  • Participation in a clinical trial of an investigational drug, concurrently or within the last 30 days. Participation in another post-marketing observational study or Registry is acceptable

Key Trial Info

Start Date :

March 4 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2026

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT06058741

Start Date

March 4 2024

End Date

November 1 2026

Last Update

April 22 2025

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

Presidio Ospedaliero Vito Fazzi /ID# 261222

Lecce, Apulia, Italy, 73100

2

Azienda Ospedaliero Universitaria Careggi /ID# 259766

Florence, Firenze, Italy, 50134

3

Ospedale San Martino /ID# 258981

Genoa, Genova, Italy, 16132

4

IRCCS Istituto Clinico Humanitas /ID# 259300

Rozzano, Lombardy, Italy, 20089

A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy | DecenTrialz